InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Berkowitz Jeffrey, Director. Officer active across 1 companies, notably Esperion Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was filed on 27 May 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
012,376 shares0
Common Stock
SEC:0001628280-21-011362·
012,376 shares0
Common Stock
SEC:0001628280-21-011362:0·
2 of 2 declarations
About Berkowitz Jeffrey
Jeffrey Berkowitz is a Director at Esperion Therapeutics, Inc. He contributes to corporate governance and the company's strategy. His role is essential for guiding the board's decisions in the biopharmaceutical sector.
